the importance of mrd assessment before allosct in all
Published 1 year ago • 70 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:36
chemotherapy and allohsct in the treatment of all
-
0:46
the importance of mrd assessment in all phases of all treatment
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:56
overview of the clinical management of patients with mf
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
7:39
understanding mrd
-
4:28
understanding myelodysplastic syndromes (mds)
-
16:04
acute lymphoblastic leukemia (all) - symptoms, pathogenesis, diagnosis - down syndrome - hematology
-
3:21
mrd testing for all in ebmt transplant centers
-
2:12
allre08 pethema: pediatric regimen for adolescents with ph-negative all
-
5:19
circulating micrornas as mrd biomarkers in pediatric all
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
3:21
mrd testing for all in ebmt transplant centers
-
0:50
mrd in the immuno-chemo era
-
3:07
how age as a prognostic factor affects treatment options for all
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:03
updated fda mrd guidelines for hematological malignancies
-
0:45
difference between quality of life & patient-reported outcomes
-
1:11
making clinical decisions with patients
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:39
the mechanism of action of navtemadlin and its role in mf